ADTX - Financial Reports List - Aditxt, Inc. - IntrinsicAlpha

Aditxt, Inc. ADTX

Healthcare - Biotechnology - NASDAQ - US

$ 2.23

-10.8 %

$ 2.69 M

Market Cap

-0.01

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-96.09%	52.35%	28.93%
Annual Report	FY	10-K	2024-12-31	-79.23%	-6.38%	-106811.38%
Quarterly Report	Q3	8-K	2024-09-30	-94.49%	28.79%	41.93%
Quarterly Report	Q2	8-K	2024-06-30	-79.96%	-32.87%	-41.13%
Quarterly Report	Q1	8-K	2024-03-31	-63.52%	-130.66%	-99.51%
Quarterly Report	Q4	8-K	2023-12-31	-56.20%	-25.68%	-3.85%
Annual Report	FY	10-K	2023-12-31	-30.90%	-14.85%	-4.52%
Quarterly Report	Q3	8-K	2023-09-30	-61.47%	-0.24%	-50.13%
Quarterly Report	Q2	8-K	2023-06-30	2.92%	2.87%	26.63%
Quarterly Report	Q1	8-K	2023-03-31	3.87%	-6.41%	5.48%

1